| AS04, an aluminum salt-and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity AM Didierlaurent, S Morel, L Lockman, SL Giannini, M Bisteau, H Carlsen, ... The Journal of immunology 183 (10), 6186-6197, 2009 | 869 | 2009 |
| Correlates of adjuvanticity: A review on adjuvants in licensed vaccines G Del Giudice, R Rappuoli, AM Didierlaurent Seminars in immunology 39, 14-21, 2018 | 572 | 2018 |
| A critical function for CD200 in lung immune homeostasis and the severity of influenza infection RJ Snelgrove, J Goulding, AM Didierlaurent, D Lyonga, S Vekaria, ... Nature immunology 9 (9), 1074-1083, 2008 | 527 | 2008 |
| Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity S Morel, A Didierlaurent, P Bourguignon, S Delhaye, B Baras, V Jacob, ... Vaccine 29 (13), 2461-2473, 2011 | 507 | 2011 |
| Sustained desensitization to bacterial Toll-like receptor ligands after resolutionof respiratory influenza infection A Didierlaurent, J Goulding, S Patel, R Snelgrove, L Low, M Bebien, ... The Journal of experimental medicine 205 (2), 323-329, 2008 | 465 | 2008 |
| Adjuvant system AS01: helping to overcome the challenges of modern vaccines AM Didierlaurent, B Laupèze, A Di Pasquale, N Hergli, C Collignon, ... Expert review of vaccines 16 (1), 55-63, 2017 | 443 | 2017 |
| The how’s and what’s of vaccine reactogenicity C Hervé, B Laupèze, G Del Giudice, AM Didierlaurent, F Tavares Da Silva npj Vaccines 4 (1), 1-11, 2019 | 386 | 2019 |
| Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion N Garçon, DW Vaughn, AM Didierlaurent Expert review of vaccines 11 (3), 349-366, 2012 | 362 | 2012 |
| Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response A Didierlaurent, I Ferrero, LA Otten, B Dubois, M Reinhardt, H Carlsen, ... The Journal of Immunology 172 (11), 6922-6930, 2004 | 351 | 2004 |
| Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells AM Didierlaurent, C Collignon, P Bourguignon, S Wouters, K Fierens, ... The Journal of Immunology 193 (4), 1920-1930, 2014 | 270 | 2014 |
| An antiinflammatory role for IKKβ through the inhibition of “classical” macrophage activation CHY Fong, M Bebien, A Didierlaurent, R Nebauer, T Hussell, D Broide, ... The Journal of experimental medicine 205 (6), 1269-1276, 2008 | 256 | 2008 |
| Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide A Didierlaurent, B Brissoni, D Velin, N Aebi, A Tardivel, E Käslin, ... Molecular and cellular biology, 2006 | 233 | 2006 |
| Role of Toll‐like receptors in costimulating cytotoxic T cell responses K Schwarz, T Storni, V Manolova, A Didierlaurent, JC Sirard, ... European journal of immunology 33 (6), 1465-1470, 2003 | 223 | 2003 |
| Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity M Coccia, C Collignon, C Hervé, A Chalon, I Welsby, S Detienne, ... npj Vaccines 2 (1), 25, 2017 | 194 | 2017 |
| How the gut senses its content. A Didierlaurent, JC Sirard, JP Kraehenbuhl, MR Neutra Cellular microbiology 4 (2), 2002 | 179 | 2002 |
| Consensus summary report for CEPI/BC March 12–13, 2020 meeting: assessment of risk of disease enhancement with COVID-19 vaccines PH Lambert, DM Ambrosino, SR Andersen, RS Baric, SB Black, RT Chen, ... Vaccine 38 (31), 4783-4791, 2020 | 173 | 2020 |
| The generation of mature, single-positive thymocytes in vivo is dysregulated by CD69 blockade or overexpression T Nakayama, DJ Kasprowicz, M Yamashita, LA Schubert, G Gillard, ... The Journal of Immunology 168 (1), 87-94, 2002 | 140 | 2002 |
| Vaccine adjuvants: a priority for vaccine research AM Harandi, D Medaglini, RJ Shattock, WG convened by EUROPRISE Vaccine 28 (12), 2363-2366, 2010 | 139 | 2010 |
| Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study AG L'Huillier, B Meyer, DO Andrey, I Arm-Vernez, S Baggio, ... Clinical Microbiology and Infection 27 (5), 784. e1-784. e8, 2021 | 136 | 2021 |
| Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approach N Garçon, S Morel, A Didierlaurent, D Descamps, M Wettendorff, ... BioDrugs 25, 217-226, 2011 | 131 | 2011 |
